Table 2 Potential treatment effect of the use of MO lipid on liver function tests, electrolytes, coagulation, and inflammation markers in the per-protocol population

Liver function test

 ALT (U/L)

12

2.56

5.22

-2.67 (-15.89–10.56)

 AST (U/L)

12

4.56

1.22

3.33 (-4.02–10.69)

 ALP (U/L)

11

-0.33

-3.77

3.44 (-38.38–45.26)

 GGT (U/L)

10

5.69

1.98

3.71 (− 3.54–10.97)

 Total bilirubin (μmol/L)

12

1.06

0.44

0.61 (− 2.55–3.78)

 Conjugated bilirubin (μmol/L)

9

 − 0.33

 − 0.50

0.17 (− 0.73 –1.06)

 Albumin (g/L)

12

 − 0.11

0.89

 − 1.00 (− 2.83–0.83)

Coagulation markers

 APTT (s)

9

 − 0.65

 − 1.85

1.20 (− 2.62–5.02)

 INR

9

 − 0.10

 − 0.15

0.05 (− 0.25–0.35)

Inflammation marker

 CRP (mg/L)

8

 − 13.50

 − 1.58

 − 11.92 (− 49.06–25.22)

General Biochemistry

 Hemoglobin (g/L)

12

 − 2.00

8.39

 − 10.39 (− 18.08– − 2.69)

 White blood cells (X10⁹/L)

12

 − 1.77

1.16

 − 2.93 (− 4.74– − 1.11)

 Platelets (X10⁹/L)

12

 − 1.89

10.11

 − 12.00 (− 38.88–14.88)

 Sodium (mmol/L)

12

 − 0.61

 − 1.50

.89 (− 2.05–3.83)

 Potassium (mmol/L)

12

0.18

 − 0.06

0.23 (− 0.07–0.54)

 Bicarbonate (mmol/L)

12

0.89

 − 0.17

1.06 (− 3.52–5.63)

 Chlorine (mmol/L)

12

0.22

 − 1.28

1.50 (− 1.64–4.64)

 Phosphate (mmol/L)

12

0.06

0.07

 − 0.00 (− 0.20–0.20)

 Calcium (mmol/L)

12

 − 0.02

0.02

 − 0.04 (− 0.14–0.06)

 Magnesium (mmol/L)

12

 − 0.00

 − 0.04

0.03 (− 0.03–0.10)